Tonix Pharmaceuticals Holding Corp. (TNXP)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 62.14M |
| Enterprise value | -76.95M |
| Trailing P/E | 0.29 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.27 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.71 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.51 |
| 52-week change 3 | -83.52% |
| S&P500 52-week change 3 | -8.38% |
| 52-week high 3 | 11.5200 |
| 52-week low 3 | 0.2900 |
| 50-day moving average 3 | 0.5684 |
| 200-day moving average 3 | 1.5747 |
Share statistics
| Avg vol (3-month) 3 | 6.97M |
| Avg vol (10-day) 3 | 8.27M |
| Shares outstanding 5 | 57.54M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 53.22M |
| % held by insiders 1 | 0.06% |
| % held by institutions 1 | 17.88% |
| Shares short (29 Dec 2022) 4 | 3.36M |
| Short ratio (29 Dec 2022) 4 | 0.32 |
| Short % of float (29 Dec 2022) 4 | 5.85% |
| Short % of shares outstanding (29 Dec 2022) 4 | 5.84% |
| Shares short (prior month 29 Nov 2022) 4 | 1.38M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 31 Oct 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:32 |
| Last split date 3 | 16 May 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -29.74% |
| Return on equity (ttm) | -50.14% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -108.4M |
| Net income avi to common (ttm) | -112.35M |
| Diluted EPS (ttm) | -7.5030 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 139.98M |
| Total cash per share (mrq) | 2.43 |
| Total debt (mrq) | 886k |
| Total debt/equity (mrq) | 0.39 |
| Current ratio (mrq) | 11.33 |
| Book value per share (mrq) | 4.29 |
Cash flow statement
| Operating cash flow (ttm) | -98.2M |
| Levered free cash flow (ttm) | -123.75M |
© 2023 Yahoo. All rights reserved.
